Top indications for Australian clinical trials from 2012 - 2016 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Top indications for Australian clinical trials from 2012 – 2016

13 Oct 2017

Top indications for Australian clinical trials from 2012 – 2016

As part of our series of white papers tracking clinical trials activity around the world, GlobalData recently compiled a summary of clinical trial in Australia. GlobalData captured records of 3,199 clinical trials across all diseases and phases that had a start date January 01, 2012, and December 31, 2016.

The largest number of global clinical trials overall took place in non-small cell lung cancer, with 122 trials, followed by type 2 diabetes, hepatitis C, solid tumour, and breast cancer. Phase II was the most frequent phase across the major indications, as shown in Figure 1, ranging from 26–48% of trials for each indication. Phase III was the second most frequent phase, making up 54% of hepatitis C trials. Phase I made up the highest percentage in solid tumour trials.